Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: Misrouted proteins as a novel disease etiology and therapeutic target

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 7, 2002, Pages 3255-3262

  Janovick, Jo Ann ^a   Maya Nunez, Guadalupe ^a   Conn, P Michael ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN RECEPTOR;

ARTICLE; CELL STRAIN COS7; DNA TEMPLATE; GENE DELETION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INTERNALIZATION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN FOLDING; RECEPTOR AFFINITY;

EID: 0036322898     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.7.8582     Document Type: Article

References (47)

1. G protein-coupled receptors and the G protein family
2. Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines
3. A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse
4. Xp22.3 deletions in isolated familial Kallmann's syndrome
5. Definitive localization of X-linked Kallmann syndrome (hypogonadism and anosmia) to Xp22.3: Close linkage to the hypervariable repeat sequence CRI-S232
6. Brief report: Intragenic deletion of the KALIG-1 gene in Kallmann's syndrome
7. X chromosome-linked Kallmann syndrome: Stop mutations validate the candidate gene
8. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency
9. A recurrent missense mutation in the KAL gene in patients with X-linked Kallmann's syndrome
10. An atypicial contiguous gene syndrome: Molecular studies in a family with X-linked Kallmann's syndrome and X-linked ichthyosis
11. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita
12. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor
13. Mutations in gonadotropin-releasing hormone receptors gene cause hypogonadotropic hypogonadism
14. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration
15. Gonadotropin-releasing hormone receptor gene mutation: A new cause of hereditary hypogonadism and another mutated G-protein-coupled receptor
16. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred
17. Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor
18. Mutations of the GnRH receptor gene: A new cause of autosomal-recessive hypogonadotropic hypogonadism
19. 90K) GnRH receptor function by a deletion at a distant site
20. Combined modification of intracellular and extracellular loci on human gonadotropin-releasing hormone receptor provides a mechanism for enhanced expression
21. Influence of a species-specific extracellular amino acid on expression and function of the human gonadotropin-releasing hormone receptor
22. Addition of catfish gonadotropin-releasing hormone (GnRH) receptor intracellular carboxyl-terminal tail to rat GnRH receptor alters receptor expression and regulation
23. Orally bioavailable, indole-based nonpeptide GnRH receptor antagonists with high potency and functional activity
24. Potent nonpeptide GnRH receptor antagonists derived from substituted indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminus
25. Substituted indole-5-carboxamides and -acetamides as potent nonpeptide GnRH receptor antagonists
26. Gene splicing by overlap extension
27. The use of lithium ion in measurement of stimulated pituitary inositol phospholipid turnover
28. Regulation of the rat pituitary gonadotropin-releasing hormone receptor
29. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction
30. The rat gonadotropin-releasing hormone receptor internalizes via a β-arrestin-independent, but dynamin-dependent, pathway: Addition of a carboxyl-terminal tail confers β-arrestin dependency
31. Agonist-induced endocytosis and recycling of the gonadotropin-releasing hormone receptor: Effect of β-arrestin on internalization kinetics
32. 6 GnRH agonists on Cos-1 cells transfected with the human GnRH receptor
33. A single amino acid substitution in transmembrane helix VI results in overexpression of the human GnRH receptor
34. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism
35. A novel homozygous mutation in the second transmembrane domain of the gonadotropin releasing hormone receptor gene
36. An intramolecular disulfide bond between conserved extracellular cysteines in the gonadotropin-releasing hormone receptor is essential for binding and activation
37. 2 receptor mutants G185C and R202C by a second site suppressor mutation
38. Functional activation of the cystic fibrosis trafficking mutant ΔF508-CFTR by overexpression
39. Increased thermal stability of protein in the presence of sugars and polyols
40. Correcting temperature-sensitive protein folding defects
41. Chemical chaperones correct the mutant phenotype of the ΔF508 cystic fibrosis transmembrane conductance regulator protein
42. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants
43. Localization of G-protein-coupled receptors in health and disease
44. Antagonists to the rescue